Prophylactic human papillomavirus vaccination to prevent recurrence of cervical intraepithelial neoplasia: a meta-analysis.
Helena C BartelsJames PostleAilin C RogersDonal BrennanPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2020)
Prophylactic or adjuvant HPV vaccination reduces the risk of recurrent cervical intraepithelial neoplasia 2+. These data support further investigation of its role as an adjuvant to surgical treatment.